Literature DB >> 2596022

Mutated and hypermutated genes of persistent measles viruses which caused lethal human brain diseases.

R Cattaneo1, A Schmid, P Spielhofer, K Kaelin, K Baczko, V ter Meulen, J Pardowitz, S Flanagan, B K Rima, S A Udem.   

Abstract

Persistent measles viruses (MVs) causing lethal human brain diseases are defective, and the structure of several mutated matrix genes has been elucidated previously. The present study of four persistent MVs revealed a high number of differences from a consensus sequence also in other genes. Amino acid changes accumulated in the carboxyl terminus of the nucleocapsid protein and in the amino terminus of the phosphoprotein, but did not significantly alter these products, which are implicated in viral replication and transcription. The contrary is true for the envelope glycoproteins: In three of four cases, mutations caused partial deletion of the short intracellular domain of the fusion protein, most likely compromising efficient viral budding. Moreover, in the hemagglutinin gene of a strain showing strongly reduced hemadsorption, 20 clustered A to G mutations, resulting in 16 amino acid changes, were detected. This hypermutation might be due to unwinding modification of a part of the MV RNA genome accidentally present in a double-stranded form. Finally, we classified four lytic and seven persistent MV strains on the basis of their sequences. Surprisingly, the four lytic viruses considered belong to the same class. The persistent viruses form more loosely defined groups, which all differ from the vaccine strain Edmonston.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2596022     DOI: 10.1016/0042-6822(89)90554-0

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  49 in total

1.  Functional and nonfunctional measles virus matrix genes from lethal human brain infections.

Authors:  I Ballart; M Huber; A Schmid; R Cattaneo; M A Billeter
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

2.  Regulation of a double-stranded RNA modification activity in human cells.

Authors:  L M Morrissey; K Kirkegaard
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

Review 3.  Measles virus, immune control, and persistence.

Authors:  Diane E Griffin; Wen-Hsuan Lin; Chien-Hsiung Pan
Journal:  FEMS Microbiol Rev       Date:  2012-03-13       Impact factor: 16.408

4.  Double-stranded RNA unwinding and modifying activity is detected ubiquitously in primary tissues and cell lines.

Authors:  R W Wagner; C Yoo; L Wrabetz; J Kamholz; J Buchhalter; N F Hassan; K Khalili; S U Kim; B Perussia; F A McMorris
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

5.  Cloning of the matrix gene of measles virus (Hallé strain).

Authors:  R Buckland; V Cheynet; P Beauverger; F Wild
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

Review 6.  Subacute sclerosing panencephalitis.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  2002-02       Impact factor: 2.401

7.  Methods for the detection of non-random base substitution in virus genes: models of synonymous nucleotide substitution in picornavirus genes.

Authors:  D Haydon; N Knowles; J McCauley
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

8.  Characterization of measles virus strains causing SSPE: a study of 11 cases.

Authors:  L Jin; S Beard; R Hunjan; D W G Brown; E Miller
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

9.  Subacute sclerosing panencephalitis virus dominantly interferes with replication of wild-type measles virus in a mixed infection: implication for viral persistence.

Authors:  A Hirano
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  The matrix proteins of neurovirulent subacute sclerosing panencephalitis virus and its acute measles virus progenitor are functionally different.

Authors:  A Hirano; A H Wang; A F Gombart; T C Wong
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.